Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 13,800 shares, a drop of 42.5% from the April 30th total of 24,000 shares. Based on an average daily trading volume, of 396,500 shares, the short-interest […]